Glaxosmithkline | GSK - القيمة السوقية

سعر السهم
51.41
التغيير اليومي
-7.71 -13.04%
شهريا
-13.25%
سنويا
29.01%
Q2 التوقعات
53.52




القيمة السوقية تغيير تاريخ
AbbVie USD 355.2B 48.64B 2026-04
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 210.86B 90.39B 2026-04
Aurora Cannabis CAD 327.21M 142.93M 2025-12
Bausch Health Companies USD 2.77B 193.57M 2026-04
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
GlaxoSmithKline GBP 78.79B 5.01B 2026-04
Glaxosmithkline GBP 99.93B 13.05B 2025-12
J&J USD 561.65B 17.5B 2026-04
Merck USD 261.26B 51.62B 2025-12
Novartis USD 231.75B 76B 2026-04
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 107.27B 72.99B 2026-04
Zoetis USD 55.45B 9.4B 2025-12